Skip to main content

Table 1 Baseline patient characteristics

From: Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer

Characteristics No. of patients (%)
Median age year, (range) 69 (51–79)
Gender
 male 26 (86.7)
 female 4 (13.4)
Median BMI, (range) 22.2 (15.3–28.5)
Primary lesion
 Upper 8 (26.7)
 Middle 11 (36.7)
 Lower 11 (36.7)
Type of gastrectomy
 Proximal 2 (6.7)
 Distal 16 (53.3)
 Total 12 (40.0)
Macroscopic type
 1 1 (3.3)
 2 5 (16.7)
 3 22 (73.3)
 5 2 (6.7)
Differentiation
 well 2 (6.7)
 mod 12 (40.0)
 poor 16 (53.3)
Tumor stage
 3 14 (46.7)
 4a 16 (53.3)
Nodal stage
 1 2 (6.7)
 2 13 (43.3)
 3a 12 (40.0)
 3b 3 (10.0)
UICC stage
 IIIA 12 (40.0)
 IIIB 9 (30.0)
 IIIC 9 (30.0)